You are here

  • Home
  • Archive
  • Volume 17, Issue 4
  • Some oral antidiabetic medications may prevent Type 2 diabetes in people at high risk for it, but the evidence is insufficient to determine whether the potential benefits outweigh the possible risks

Article Text

Article menu
Download PDFPDF
Therapeutics
Systematic review and meta-analysis
Some oral antidiabetic medications may prevent Type 2 diabetes in people at high risk for it, but the evidence is insufficient to determine whether the potential benefits outweigh the possible risks

https://doi.org/10.1136/ebmed-2011-100332

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests AJK has received professional consultancy fees, grant funding and/or fees for consultancies and lectures from Astra Zeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, NovoNordisk, Pfizer, Servier and Takeda.